Edition:
United States

EUROPE

FILE PHOTO: Syringes are seen in front of displayed Biontech and Pfizer...

Instant View: Pfizer ends COVID-19 trial with 95% efficacy

Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine showed it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.S. authorization within days.

FILE PHOTO: The word

Q&A: Where are we in the COVID-19 vaccine race?

Drugmakers and research centers around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway.

World Video